参考文献/References:
1 中华医学会骨科学分会. 骨质疏松骨折诊疗指南 [J]. 中华骨科杂志, 2008, 28(10): 875-878.
2 邱贵兴, 裴福兴, 胡侦明, 等. 中国骨质疏松性骨折诊疗指南（骨质疏松性骨折诊断及治疗原则） [J]. 中华骨与关节外科杂志, 2015 (5): 371-374.
3 Bliuc D, Nguyen ND, Alarkawi D, et al. Accelerated bone loss and increased post-fracture mortality in elderly women and men [J]. Osteoporo Int, 2015, 26(4): 1331-1339.
4 孙爱军, 林守清, 余卫, 等. 经皮用雌二醇预防中国妇女绝经早期骨丢失 [J]. 中华医学杂志(英文版), 2002, 115(12): 1790-1795.
5 Schmder HM, Peterson KK, Erlandsen M. Occurrence and incidence of the second hip fracture [J]. Clin Orthop, 1993, 289: 166-169.
6 Goldhahn J, Little D, Mitchell P, et al. Evidence for anti-osteoporosis therapy in acute fracture situations--recommendations of a multidisciplinary workshop of the International Society for Fracture Repair [J]. Bone, 2010, 46(2): 267-271.
7 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊治指南 [J]. 中华骨质疏松和骨矿盐疾病杂志, 2011, 4(1): 2-17.
8 吴青, 朱汉民. 骨质疏松基础防治措施对老年人25羟基维生素D水平和下肢肌力及平衡功能的影响 [J]. 中华老年医学杂志, 2014, 33(10): 1135-1138.
9 张秀珍, 宣淼, 李颖, 等. 一项为期18个月、多中心应用重组人甲状旁腺激素(1-34)与依降钙素治疗绝经后骨质疏松症的随机、对照临床试验研究 [J]. 中华内分泌代谢杂志, 2015 (2): 120-126.
10 李国新, 袁忠治, 温健, 等. 口服及静脉应用双磷酸盐治疗绝经后的骨质疏松临床研究 [J]. 中国骨质疏松杂志, 2013, 19(9): 988-990.
11 陈琳, 游利, 陈瑾瑜, 等. 应用阿仑膦酸钠治疗绝经后骨质疏松失效改用雷洛昔芬的疗效观察 [J]. 中华骨质疏松和骨矿盐疾病杂志, 2015 (2): 132-137.
12 Khosla S. Increasing options for the treament of osteoporosis [J]. N Engl J Med, 2009, 361(8): 818-820.
13 Cosman F, Eriksen EF, Recknor C, et al. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis [J]. J Bone Miner Res, 2011, 26(3): 503-511.
14 Eriksen EF, Keaveny TM, Gallagher ER, et al. Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis [J]. Bone, 2014, 67: 246-256.
15 Sone T, Masako I, Fukunaga M, et al. The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk [J]. Bone, 2014 (64): 75-81.
16 余倩, 吴晶. 骨质疏松症患者药物依从性及影响因素分析 [J]. 中国骨质疏松杂志, 2014, 20(7): 789-794.
17 Balasubramanian A, Tosi LL, Lane JM, et al. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009 [J]. J Bone Joint Surg Am, 2014, 96(7): e52.
18 Klop C, Gibson-Smith D, Elders PJ, et al. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010 [J]. Osteoporos Int, 2015, 26(7): 1919-1928.
相似文献/References:
[1]马晓龙,刘强,吴斗,等.骨质疏松显微骨折早期发生发展过程的实验研究[J].中华老年骨科与康复电子杂志,2016,(03):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
Ma Xiaolong,Liu Qiang,Wu Dou,et al.Experimental study of osteoporotic microsurgery fractures in the early development process[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(05):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
[2]崔红旺,蒋电明.骨细胞程序性死亡在骨质疏松中作用的研究进展[J].中华老年骨科与康复电子杂志,2016,(03):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
Cui Hongwang,Jiang Dianming.Effect of the programmed cell death of osteocyte on osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(05):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
[3]李子怡,李玉坤.OPG/RANK/RANKL信号通路在骨质疏松症中的研究进展和应用[J].中华老年骨科与康复电子杂志,2017,(02):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
Li Ziyi,Li Yukun.Researching progress and application of OPG-RANK-RANKL signaling pathway in osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
[4]雷涛,申勇.老年骨质疏松性椎体骨折若干问题的探讨[J].中华老年骨科与康复电子杂志,2017,(04):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
Lei Tao,Shen Yong..A brief discussion of osteoporotic vertebral fractures in elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
[5]马树伟.球囊扩张椎体成形术治疗急性与亚急性期骨质疏松椎体压缩骨折的疗效对比[J].中华老年骨科与康复电子杂志,2017,(06):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
Ma Shuwei.Clinical efficacy of percutaneous kyphoplasty in the treatment of acute and subacute phase of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
[6]刘伟,傅光涛,胡旭民,等.唑来膦酸治疗绝经后骨质疏松发生脆性骨折的临床研究[J].中华老年骨科与康复电子杂志,2017,(06):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
Liu Wei,Fu Guangtao,Hu Xumin,et al.Analysis in postmenopausal osteoporosis patients with fragility fracture during zoledronic acid treatment[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(05):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
[7]梁伟,吴斗,赵恩哲,等.皮质厚度在骨质疏松性髋部骨折中的应用研究[J].中华老年骨科与康复电子杂志,2018,(03):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
Liang Wei,Wu Dou,Zhao Enzhe,et al.Application research of Cortical thickness in osteoporotic hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
[8]谢亚明,谢国盛,林蒙,等.网袋成形术与椎体后凸成形术治疗骨质疏松性椎体压缩骨折的早期疗效比较[J].中华老年骨科与康复电子杂志,2018,(04):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
Xie Yaming,Xie Guosheng,Lin Meng,et al.Early clinical outcome of vesselplasty and kyphoplasty in treatment of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
[9]吴石磊 刘勇 邵增务 田青. 骨组织细胞外泌体对骨代谢作用的研究现状[J].中华老年骨科与康复电子杂志,2018,(05):308.
Wu Shilei,Liu Yong,Shao Zengwu,et al. Research status of bone tissue-derived exosomes on bone metabolism[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):308.
[10]王建华.骨质疏松症治疗药物的分类与用药选择[J].中华老年骨科与康复电子杂志,2019,(05):297.[doi:10.3877/cma.j.issn.2096-0263.2019.05.010]
Wang Jianhua.Classification and selection of drugs for treating osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(05):297.[doi:10.3877/cma.j.issn.2096-0263.2019.05.010]
[11]邢浩,刘强,吴斗,等.双膦酸盐治疗股骨非典型性骨折的研究进展[J].中华老年骨科与康复电子杂志,2018,(02):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
Bisphosphonates and atypical femur fractures femur[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(05):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
[12]李沫,王海旸,王丽娟,等.老年骨质疏松常用治疗药物的研究现状及展望[J].中华老年骨科与康复电子杂志,2019,(06):365.[doi:10.3877/cma.j.issn.2096-0263.2019.06.011]
Li Mo,Wang Haiwei,Wang Lijuan,et al.The present and progress of common drug therapy in treating senile osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2019,(05):365.[doi:10.3877/cma.j.issn.2096-0263.2019.06.011]
[13]张亚玲,王琳,王敬贤,等.双膦酸盐治疗骨质疏松症与总死亡率相关性的meta分析[J].中华老年骨科与康复电子杂志,2020,(05):304.[doi:10.3877/cma.j.issn.2096-0263.2020.05.010]
ZhangYaling,WangLin,Wang Jingxian,et al.The relationship between bisphosphonates and total mortality in patients with osteoporosis: A Meta-Analysis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2020,(05):304.[doi:10.3877/cma.j.issn.2096-0263.2020.05.010]